Verition Fund Management
TERN

Verition Fund Management’s Terns Pharmaceuticals TERN Stock Holding History

Verition Fund Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-750,000
Closed -$39.5M – 2502
2026
Q1 		$39.5M Buy
+750,000
New +$30.8M 0.26% 58

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Verition Fund Management's TERN Position: Q2 2026 in Review

Verition Fund Management sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 802,293 shares — an estimated $42.3M sold.

Verition Fund Management first reported a position in TERN in Q1 2023 and held it in 5 quarters. The position peaked at $42.3M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • Verition Fund Management reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 802,293 Terns Pharmaceuticals shares in Q2 2026, an estimated $42.3M.
  • Verition Fund Management first reported a position in Terns Pharmaceuticals in Q1 2023 and held it in 5 quarters.
  • Verition Fund Management's Terns Pharmaceuticals position peaked at $42.3M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.